Published by The Moderate Voice Efforts to reduce tensions between the Koreas, like the 2018 inter-Korean summit, are frequently the target of disinformation campaigns in
Day: November 15, 2021
Zenith and Newsoara Biopharma Announce Expanded Licensing and Investment
CALGARY, Alberta, Nov. 15, 2021 (GLOBE NEWSWIRE) — Zenith Capital Corp. (“Zenith” or the “Company”) announced today that Zenith Epigenetics Ltd. (“Zenith Epigenetics”), a wholly-owned subsidiary of Zenith Capital, has entered into a licensing agreement with Newsoara Biopharma Co., Ltd. (“Newsoara”) for Zenith Epigenetics’ lead compound, ZEN-3694, in Asia excluding Middle East and North Africa […]
Junshi Biosciences and Coherus Announce Toripalimab Granted Orphan Drug Designation in the United States for Esophageal Cancer
SHANGHAI, China and REDWOOD CITY, Calif., Nov. 15, 2021 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd. (“Junshi Biosciences”, HKEX: 1877; SSE: 688180) and Coherus Biosciences, Inc. (“Coherus”, Nasdaq: CHRS) announced today that the United States Food and Drug Administration (“FDA”) has granted Orphan Drug Designation (ODD) for toripalimab for the treatment of esophageal cancer. Orphan […]
kt Rolster releases Ucal, HyBriD, and Zzus
Published by Inven Global On Nov. 15, kt Rolster announced through their Facebook page that they were releasing mid laner Son “Ucal” Woo-hyeon. Ucal’s original
Review: The 2022 Kia Carnival Makes a Case for the Sexy Minivan
Published by InsideHook By Benjamin Hunting A funny thing happened when buyers fled the minivan market as part of the mid-2000s cultural migration towards the
CoImmune, Inc. Appoints Ed Baracchini, PhD, Chairman of the Board of Directors
DURHAM, N.C., Nov. 15, 2021 (GLOBE NEWSWIRE) — CoImmune, Inc., a clinical stage immuno-oncology company working to redefine cancer treatment using best-in-class cellular immunotherapies, today announced the appointment of Dr. Ed Baracchini as chairman of the Company’s board of directors. “As a member of the CoImmune board of directors, Dr. Baracchini has provided strong counsel […]
Digihost’s October Bitcoin Production Value Increases 1,486% Over October 2020 and up 56% From September
TORONTO, Nov. 15, 2021 (GLOBE NEWSWIRE) — Digihost Technology Inc. (“Digihost” or the “Company”) (TSXV: DGHI; Nasdaq: DGHI), an innovative North American based Bitcoin self-mining company, is pleased to provide an unaudited Bitcoin (“BTC”) production update for the month ended October 31, 2021. All amounts are expressed in USD unless otherwise indicated. The Company is […]
Adagio Therapeutics Provides Update for ADG20 COVID-19 Antibody Program and Reports Third Quarter 2021 Financial Results
FDA Feedback Supports Planned Emergency Use Authorization (EUA) Submission for ADG20 for Prevention of COVID-19; Interim Clinical Data Package from EVADE Prevention Trial to Support EUA Submission Expected in Second Quarter 2022 Enrollment Progressing in ADG20 STAMP Trial for Treatment of COVID-19; Planned Interim Efficacy Analysis Expected in Second Quarter 2022 to Support Potential EUA […]
International Handball Federation partners with Sportradar Integrity Services
Sportradar’s proven fraud detection services to help protect the integrity of global handball competition BASEL, Switzerland & ST GALLEN, Switzerland, Nov. 15, 2021 (GLOBE NEWSWIRE) — The International Handball Federation (IHF) and Sportradar Integrity Services – a global supplier of sport integrity solutions and partner to over 100 sports federations and leagues – have today […]
Innovation Zed Announce 2022 Launch of InsulCheck DOSE Add-on Technology for Insulin Pens
InsulCheck DOSE by Innovation Zed DUBLIN, Nov. 15, 2021 (GLOBE NEWSWIRE) — Innovation Zed, developer of novel diabetes management technologies (the InsulCheck range), headquartered at NovaUCD, at University College Dublin, Ireland are delighted to announce today the arrival of the much anticipated InsulCheck DOSE technology that will be coming to market in 2022. “It is […]